A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD3.94
- USD4.20
- USD3.68
- USD5.10
- -11.50%
- 15M
- 8.52M
- 1.49M
- 781M
- 2.71
- 26.10%
Stock News
53 minutes ago
Trump is going to Davos — here are the big names who aren't
CNBC
1 hour ago
Global industrial stocks feel the benefit of the biggest hedge fund buying in ten years
MarketWatch
2 hours ago
SBA Communications Corporation Announces Tax Reporting Information for 2025 Distributions
Yahoo
2 hours ago
'PTO-maxxing' is the key to making the most of your time off in 2026—here's how to do it
CNBC